2026 NPPES data Ophthalmology Physician NPI 1285613273 MD
Verify on CMS →

MARK TANNENBAUM, MD

Ophthalmology Physician in WATERBURY, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 355 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
56%
generic claims · 44% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

MARK TANNENBAUM, MD filed 2,016 Medicare Part D claims in 2023 as a Ophthalmology Physician in WATERBURY, Connecticut, prescribing 56% generic.

2K
Part D claims, 2023
56%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK TANNENBAUM, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

2,016 Top 16% higher than 84% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MARK TANNENBAUM, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK TANNENBAUM, MD?

Quality data not reported

NPI registry status

Active

Issued 01/10/2006

NPI 1285613273

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

2,016 42% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

Specialty distribution in Connecticut

How Ophthalmology Physician compares to other specialties among Connecticut providers

Connecticut providers

Ophthalmology Physician share within Connecticut

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Connecticut

Specialty board-certification context

Estimated specialty board-certified rate — Ophthalmology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ophthalmology Physician ABMS/AOA estimate

Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK TANNENBAUM, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 87 GRANDVIEW AVE, WATERBURY, CT, 06708, with a listed phone of (203) 574-2020. NPI 1285613273 was issued on 01/10/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TANNENBAUM most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,016 prescription claims written by this provider, covering 355 Medicare beneficiaries and totaling roughly $486K in drug spend, split 44% brand-name and 56% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

87 GRANDVIEW AVE
WATERBURY, CT 06708

Provider Details

NPI 1285613273
Specialty Ophthalmology Physician
Credentials MD
Gender Male
NPI Issued 01/10/2006

Hospital and facility affiliations

Facilities where MARK TANNENBAUM, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CHINATOWN TRUE CARE MEDICAL PLLC
NEW YORK, NY
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NEW YORK, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Above average

MARK TANNENBAUM, MD — brand share 44.0%
Specialty average (est.)

44% brand-name claims vs 56% generic, on 2,016 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,016
Total Claims
$486K
Total Drug Cost
355
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,244
Total Day Supply
125,183
Brand vs Generic
44% brand / 56% generic
Brand Drug Cost
$396K
Generic Drug Cost
$91K

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
1.36
Gender Split
56% female / 44% male
Age Distribution
<65: 50, 65-74: 140, 75-84: 126, 85+: 39

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK TANNENBAUM, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
734
Dorzolamide Hcl
133
Combigan
Brimonidine Tartrate/Timolol
115
Brinzolamide
113
Rhopressa
Netarsudil Mesylate
111
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
106
Simbrinza
Brinzolamide/Brimonidine Tart
96
Lumigan
Bimatoprost
95
Timolol Maleate
74
Brimonidine Tartrate-Timolol
Brimonidine Tartrate/Timolol
65

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How MARK TANNENBAUM, MD fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

MARK TANNENBAUM, MD's 2,016 claims are above the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as TANNENBAUM.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK TANNENBAUM, MD's specialty?
MARK TANNENBAUM, MD specializes in Ophthalmology Physician and practices in WATERBURY, Connecticut. Credentials: MD.
How much does MARK TANNENBAUM, MD prescribe under Medicare Part D?
In 2023, MARK TANNENBAUM, MD wrote 2,016 Medicare Part D claims totaling $486K in drug costs for 355 beneficiaries.
Where is MARK TANNENBAUM, MD located?
MARK TANNENBAUM, MD is located at 87 GRANDVIEW AVE, WATERBURY, CT, 06708. Phone: (203) 574-2020.
What is MARK TANNENBAUM, MD's NPI number?
MARK TANNENBAUM, MD's National Provider Identifier (NPI) is 1285613273, issued on 01/10/2006.
Does MARK TANNENBAUM, MD prescribe more brand-name or generic drugs?
MARK TANNENBAUM, MD's prescribing is 44% brand-name and 56% generic drugs by claim count, with $396K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does MARK TANNENBAUM, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK TANNENBAUM, MD's most frequently prescribed drugs include Latanoprost, Dorzolamide Hcl, Combigan. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK TANNENBAUM, MD accept Medicare?
MARK TANNENBAUM, MD appears in CMS Medicare data with 2,016 Part D claims and 355 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK TANNENBAUM, MD's credentials?
MARK TANNENBAUM, MD's NPI is 1285613273 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology